Literature DB >> 31999201

Focused ultrasound induced-blood-brain barrier opening in mouse brain receiving radiosurgery dose of radiation enhances local delivery of systemic therapy.

Shutao Wang1,2, Cheng-Chia Wu2, Hairong Zhang3, Maria Eleni Karakatsani3, Yi-Fang Wang2, Yang Han3, Kunal R Chaudhary2, Cheng-Shie Wuu2, Elisa Konofagou3, Simon K Cheng2.   

Abstract

OBJECTIVE: Investigate the temporal effects of focused ultrasound (FUS)-induced blood-brain barrier (BBB) opening in post-radiotherapy mouse brains. METHODS AND MATERIALS: C57B6 mice without tumors were used to simulate the scenario after gross total resection (GTR) of brain tumor. Radiation dose of 6 Gy x 5 was delivered to one-hemisphere of the mouse brain. FUS-induced BBB-opening was delivered to the irradiated and non-irradiated brain and was confirmed with MRI. Dynamic MRI was performed to evaluate blood vessel permeability. Two time points were selected: acute (2 days after radiation) and chronic (31 days after radiation).
RESULTS: BBB opening was achieved after FUS in the irradiated field as compared to the contralateral non-irradiated brain without any decrease in permeability. In the acute group, a trend for higher gadolinium concentration was observed in radiated field.
CONCLUSION: Localized BBB-opening can be successfully achieved without loss of efficacy by FUS as early as 2 days after radiotherapy. ADVANCES IN KNOWLEDGE: Adjuvant radiation after GTR is commonly used for brain tumors. Focused ultrasound facilitated BBB-opening can be achieved without loss of efficacy in the post-irradiated brain as early as 2 days after radiation therapy. This allows for further studies on early application of FUS-mediated BBB-opening.

Entities:  

Mesh:

Year:  2020        PMID: 31999201      PMCID: PMC7217580          DOI: 10.1259/bjr.20190214

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

1.  Permeability assessment of the focused ultrasound-induced blood-brain barrier opening using dynamic contrast-enhanced MRI.

Authors:  F Vlachos; Y-S Tung; E E Konofagou
Journal:  Phys Med Biol       Date:  2010-08-25       Impact factor: 3.609

Review 2.  Targeted delivery of protein and gene medicines through the blood-brain barrier.

Authors:  W M Pardridge
Journal:  Clin Pharmacol Ther       Date:  2014-12-15       Impact factor: 6.875

3.  Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.

Authors:  Cheng-Chia Wu; Kunal R Chaudhary; Yong Hum Na; David Welch; Paul J Black; Adam M Sonabend; Peter Canoll; Yvonne M Saenger; Tony J C Wang; Cheng-Shie Wuu; Tom K Hei; Simon K Cheng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-19       Impact factor: 7.038

Review 4.  Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma.

Authors:  S S Agarwala; J M Kirkwood
Journal:  Oncologist       Date:  2000

5.  A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI.

Authors:  Gesthimani Samiotaki; Fotios Vlachos; Yao-Sheng Tung; Elisa E Konofagou
Journal:  Magn Reson Med       Date:  2011-08-19       Impact factor: 4.668

Review 6.  Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.

Authors:  Komal Anjum; Bibi Ibtesam Shagufta; Syed Qamar Abbas; Seema Patel; Ishrat Khan; Sayed Asmat Ali Shah; Najeeb Akhter; Syed Shams Ul Hassan
Journal:  Biomed Pharmacother       Date:  2017-06-03       Impact factor: 6.529

7.  Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

Authors:  Manabu Kinoshita; Nathan McDannold; Ferenc A Jolesz; Kullervo Hynynen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

8.  Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.

Authors:  Kuo-Chen Wei; Po-Chun Chu; Hay-Yan Jack Wang; Chiung-Yin Huang; Pin-Yuan Chen; Hong-Chieh Tsai; Yu-Jen Lu; Pei-Yun Lee; I-Chou Tseng; Li-Ying Feng; Peng-Wei Hsu; Tzu-Chen Yen; Hao-Li Liu
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

Review 9.  Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Authors:  Jann N Sarkaria; Leland S Hu; Ian F Parney; Deanna H Pafundi; Debra H Brinkmann; Nadia N Laack; Caterina Giannini; Terence C Burns; Sani H Kizilbash; Janice K Laramy; Kristin R Swanson; Timothy J Kaufmann; Paul D Brown; Nathalie Y R Agar; Evanthia Galanis; Jan C Buckner; William F Elmquist
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

10.  Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study.

Authors:  Todd Mainprize; Nir Lipsman; Yuexi Huang; Ying Meng; Allison Bethune; Sarah Ironside; Chinthaka Heyn; Ryan Alkins; Maureen Trudeau; Arjun Sahgal; James Perry; Kullervo Hynynen
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

View more
  2 in total

Review 1.  The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.

Authors:  Chulyong Kim; Michael Lim; Graeme F Woodworth; Costas D Arvanitis
Journal:  J Neurooncol       Date:  2022-03-02       Impact factor: 4.506

Review 2.  Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients.

Authors:  Jordina Rincon-Torroella; Harmon Khela; Anya Bettegowda; Chetan Bettegowda
Journal:  J Neurooncol       Date:  2021-10-06       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.